The hinge region in androgen receptor control

被引:76
作者
Clinckemalie, Liesbeth [1 ]
Vanderschueren, Dirk [2 ]
Boonen, Steven [3 ]
Claessens, Frank [1 ]
机构
[1] Katholieke Univ Leuven, Dept Cellular & Mol Med, Mol Endocrinol Lab, B-3000 Louvain, Belgium
[2] Katholieke Univ Leuven, Div Clin & Expt Endocrinol, B-3000 Louvain, Belgium
[3] Katholieke Univ Leuven, Dept Expt Med, Div Gerontol & Geriatr, B-3000 Louvain, Belgium
关键词
Androgen receptor hinge region; Nuclear translocation; DNA binding; Posttranslational modifications; HUMAN PROSTATE-CANCER; EPIDERMAL-GROWTH-FACTOR; LIGAND-BINDING DOMAIN; RING FINGER PROTEIN; N-TERMINAL DOMAIN; NUCLEAR RECEPTOR; DNA-BINDING; STRUCTURAL BASIS; GENE-EXPRESSION; LIVING CELLS;
D O I
10.1016/j.mce.2012.02.019
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The region between the DNA-binding domain and the ligand-binding domain of nuclear receptors is termed the hinge region. Although this flexible linker is poorly conserved, diverse functions have been ascribed to it. For the androgen receptor (AR), the hinge region and in particular the (RKLKKL634)-R-629 motif, plays a central role in controlling AR activity, not only because it acts as the main part of the nuclear translocation signal, but also because it regulates the transactivation potential and intranuclear mobility of the receptor. It is also a target site for acetylation, ubiquitylation and methylation. The interplay between these different modifications as well as the phosphorylation at serine 650 will be discussed here. The hinge also has an important function in AR binding to classical versus selective androgen response elements. In addition, the number of coactivators/corepressors that might act via interaction with the hinge region is still growing. The importance of the hinge region is further illustrated by the different somatic mutations described in patients with androgen insensitivity syndrome and prostate cancer. In conclusion, the hinge region serves as an integrator for signals coming from different pathways that provide feedback to the control of AR activity. (c) 2012 Published by Elsevier Ireland Ltd.
引用
收藏
页码:1 / 8
页数:8
相关论文
共 81 条
[41]  
Kim HL, 2001, CANCER RES, V61, P2833
[42]   Lysine Methylation and Functional Modulation of Androgen Receptor by Set9 Methyltransferase [J].
Ko, Soyoung ;
Ahn, Jungmi ;
Song, Chung S. ;
Kim, Soyoung ;
Knapczyk-Stwora, Katarzyna ;
Chatterjee, Bandana .
MOLECULAR ENDOCRINOLOGY, 2011, 25 (03) :433-444
[43]   Methylation of p53 by Set7/9 mediates p53 acetylation and activity in vivo [J].
Kurash, Julia K. ;
Lei, Hong ;
Shen, Qiong ;
Marston, Wendy L. ;
Granda, Brian W. ;
Fan, Hong ;
Wall, Daniel ;
Li, En ;
Gaudet, Francois .
MOLECULAR CELL, 2008, 29 (03) :392-400
[44]   Activating signal cointegrator 1 is highly expressed in murine testicular Leydig cells and enhances the ligand-dependent transactivation of androgen receptor [J].
Lee, YS ;
Kim, HJ ;
Lee, HJ ;
Lee, JW ;
Chun, SY ;
Ko, SK ;
Lee, K .
BIOLOGY OF REPRODUCTION, 2002, 67 (05) :1580-1587
[45]   Phosphorylation-dependent ubiquitylation and degradation of androgen receptor by Akt require Mdm2 E3 ligase [J].
Lin, HK ;
Wang, L ;
Hu, YC ;
Altuwaijri, S ;
Chang, CS .
EMBO JOURNAL, 2002, 21 (15) :4037-4048
[46]   Targeting the BAF57 SWI/SNF subunit in prostate cancer: A novel platform to control androgen receptor activity [J].
Link, Kevin A. ;
Balasubramaniam, Sucharitha ;
Sharma, Ankur ;
Comstock, Clay E. S. ;
Godoy-Tundidor, Sonia ;
Powers, Nathan ;
Cao, Khanh H. ;
Haelens, Annemie ;
Claessens, Frank ;
Revelo, Monica P. ;
Knudsen, Karen E. .
CANCER RESEARCH, 2008, 68 (12) :4551-4558
[47]  
Liu L, 1999, MOL CELL BIOL, V19, P1202
[48]   ANDROGENS REGULATE PROLIFERATION OF HUMAN PROSTATE-CANCER CELLS IN CULTURE BY INCREASING TRANSFORMING GROWTH-FACTOR-ALPHA (TGF-ALPHA) AND EPIDERMAL GROWTH-FACTOR (EGF)/TGF-ALPHA RECEPTOR [J].
LIU, XH ;
WILEY, HS ;
MEIKLE, AW .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 77 (06) :1472-1478
[49]   EXPRESSION OF NERVE GROWTH-FACTOR AND NERVE GROWTH-FACTOR RECEPTOR GENES IN HUMAN TISSUES AND IN PROSTATIC ADENOCARCINOMA CELL-LINES [J].
MACGROGAN, D ;
SAINTANDRE, JP ;
DICOU, E .
JOURNAL OF NEUROCHEMISTRY, 1992, 59 (04) :1381-1391
[50]  
MacLean Helen E, 2004, Hum Mutat, V23, P287, DOI 10.1002/humu.9221